Tolerance of Anti-CMV Prophylaxis with Valganciclovir One-Year Treatment in D+/R- Lung Transplant Patients. A Single-Center Retrospective Study

Christopher D. Roy(Hôpital Foch), Antoine Roux(Eiffage (France)), S. De Miranda, Olivier Brugière(Inserm), Sylvie Colin de Verdière(Université de Versailles Saint-Quentin-en-Yvelines), L. Beaumont(Hôpital Foch), A. Hamid(Hôpital Foch), Éric Farfour(European Foundation for Clinical Nanomedicine), C. Picard(Hôpital Foch), François Parquin(Hôpital Foch)
The Journal of Heart and Lung Transplantation
March 20, 2021
Cited by 0


Related Papers